secwatch.observer — SEC 8-K summary
======================================

Issuer:     Hims & Hers Health, Inc. (HIMS)
CIK:        0001773751
Form:       8-K
Filed at:   2022-06-08T23:59:59+00:00
Accession:  0001193125-22-170297
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Hims & Hers stockholders approve all proposals at 2022 annual meeting
---------------------------------------------------------------------

- Elected ten directors, including CEO Andrew Dudum, with over 1.5B votes each; broker non-votes ~41.4M.
- Ratified KPMG as independent auditor for FY2022: 1.57B for, 656,788 against, 617,606 abstentions.
- Advisory say-on-pay approved: 1.53B for, 3.2M against, 725,386 abstentions.
- Stockholders chose one-year frequency for future advisory votes on executive compensation.
- Board determined to hold annual say-on-pay votes until next frequency vote expected at 2028 meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1773751/000119312522170297/0001193125-22-170297-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1773751/000119312522170297/d366437d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-170297

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer